Fertility Services Market Size, Share & Industry Analysis, By Service Type (Fertility Testing & Diagnostic Services, Non-ART Fertility Treatment Services, Assisted Reproductive Technology Services, Fertility Preservation Services, and Fertility-Restoring Surgical Services), By Infertility Cause (Female-Factor Infertility, Male-Factor Infertility, and Others), By Service Provider (Fertility Clinics, Hospital-Based Fertility Centers, and Others), and Regional Forecast, 2026-2034

The global fertility services market size was valued at USD 32.38 billion in 2025 and is projected to grow from USD 35.11 billion in 2026 to USD 70.99 billion by 2034, exhibiting a CAGR of 9.2% during the forecast period. Asia Pacific dominated the fertility services market with a market share of 39.04% in 2025.

The market includes assisted reproductive technology services such as IVF and ICSI, fertility preservation services including egg and sperm freezing, diagnostic services for identifying female- and male-factor causes of infertility, and donor services, delivered through fertility clinics, hospitals, and other specialized care settings. Market growth is driven by rising global infertility prevalence, increasing maternal age and delayed parenthood, expanding employer-sponsored and government-mandated insurance coverage for fertility treatment, and growing social acceptance of assisted reproduction. Moreover, technological advancements in AI-assisted embryo selection, digital specimen management, and laboratory automation are also projected to have a positive impact on market growth.

• For instance, in June 2026, Overture Life launched its ICSI.A Center of Excellence Program, bringing an automated intracytoplasmic sperm injection platform into clinical use across five fertility centers spanning Latin America, Europe, and Asia.  

Furthermore, many key industry players, such as IVI RMA Global, Jinxin Fertility Group Limited, Virtus Health, Monash IVF Group Limited, and Inception Fertility, LLC operating in the market are focusing on expanding coverage access, laboratory automation, and clinic networks to strengthen their position.

Download Free sample to learn more about this report.

Fertility Services Market Key Takeaways

Global Market Size & Forecast

• 2025 Market Size: USD 32.38 billion
• 2026 Market Size: USD 35.11 billion
• 2034 Forecast Market Size: USD 70.99 billion
• CAGR: 9.2% from 2026–2034

Market Share

• Asia Pacific dominated the fertility services market with a 39.04% share in 2025.
• Fertility preservation services segment is projected to grow at a 10.2% CAGR during the forecast period.
• Male-factor infertility segment is projected to grow at a 10.1% CAGR during the forecast period.

Key Regional Highlights

Asia Pacific

Asia Pacific is estimated to reach USD 13.80 billion in 2026 and maintain its leading position.

North America

North America reached USD 10.18 billion in 2025, reflecting continued regional expansion.

Europe

Europe is projected to grow at a 7.9% rate and reach USD 8.65 billion by 2026.

U.S.

The market is estimated at approximately USD 10.33 billion in 2026, accounting for 29.4% of global sales.

Japan

The market is estimated at approximately USD 2.49 billion in 2026, accounting for 7.1% of global revenues.

Read More

FERTILITY SERVICES MARKET TRENDS

AI-Powered Embryo Selection is an Emerging Trend Observed in Market

Fertility clinics are increasingly integrating artificial intelligence into IVF laboratories to support embryo assessment. AI-based systems analyze embryo images and developmental data to grade embryos with greater consistency than manual visual evaluation, which has traditionally depended on individual embryologists' subjective judgment. This shift is helping laboratories standardize embryo selection, shorten the time needed to reach a confident transfer decision, and improve transparency for patients navigating the IVF process. The approach is also being positioned as a way to reduce the number of embryos required for transfer, addressing clinical and ethical concerns tied to multiple pregnancies.

• For instance, in August 2025, Nova IVF Fertility partnered with Kai Health to roll out Vita Embryo, an AI-based embryo assessment tool, across its clinic network in India.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Infertility Prevalence and Expanding Insurance Mandates to Drive Market Growth

Growing infertility prevalence, linked to delayed parenthood, lifestyle-related reproductive disorders, and greater awareness of treatment options, continues to expand the pool of people seeking fertility care. In addition, legislative momentum toward mandated insurance coverage is unlocking demand which will eventually expected to drive the global fertility services market growth. As more regions require large-group health plans to cover infertility diagnosis and treatment, patients who had delayed or avoided care due to affordability are gaining a practical pathway to treatment, widening the addressable patient base for fertility service providers.

• For instance, in January 2026, California's Senate Bill 729 took effect, requiring fully insured large-group health plans to cover the diagnosis and treatment of infertility, including IVF.

MARKET RESTRAINTS

High Treatment Costs and Uneven Insurance Coverage to Restrict Market Growth

Despite growing legislative support in select regions, fertility treatment remains largely self-funded for most patients globally. A single treatment pathway often spans multiple cycles, compounding the cumulative financial burden on patients. Insurance coverage for infertility diagnosis and treatment also varies considerably across states and countries, meaning many prospective patients still lack a funded route to care. This affordability gap continues to deter a meaningful share of people experiencing infertility from initiating or completing treatment, particularly in markets without government-backed reimbursement programs.

MARKET OPPORTUNITIES

Expansion of Employer-Sponsored Fertility Benefits to Offer Significant Market Opportunities

A growing number of employers are adding fertility and family-building coverage to their benefits packages as a tool to attract and retain talent, creating a funding channel for treatment that does not rely solely on individual insurance or out-of-pocket payment. This shift is increasingly extending beyond large corporations, with new benefit models designed to make fertility coverage accessible to small and mid-size employers as well. As adoption broadens across employer segments, workplace-funded benefits are becoming a significant channel through which patients access fertility services, representing a meaningful opportunity for providers and benefit administrators alike.

• For instance, in April 2026, Progyny launched Progyny Select, a fully insured supplemental fertility and family-building plan designed to extend coverage access to small and mid-size U.S. employers.

MARKET CHALLENGES

Shortage of Skilled Embryologists and Reproductive Specialists to Challenge Market Growth

The industry faces a persistent shortage of specialized clinical talent, including embryologists and reproductive endocrinologists, whose training pathways are lengthy and limited in capacity. As patient demand for treatment continues to rise, this workforce gap is constraining how quickly clinics and hospital-based centers can expand capacity, contributing to longer patient wait times and upward pressure on specialist compensation. Addressing this shortage requires sustained investment in training infrastructure, which many individual providers are not positioned to build alone.

• For instance, in 2025, the American Society for Reproductive Medicine launched the Clinical Embryology Learning Laboratory, a national training program developed with the Society for Reproductive Biologists and Technologists and supported by CooperSurgical, to expand the pipeline of trained embryologists.

Segmentation Analysis

By Service Type

Definitive Treatment Pathway for a Broad Range of Infertility Causes Boosted Assisted Reproductive Technology Services Segment Growth

Based on service type, the market is divided into fertility testing & diagnostic services, non-art fertility treatment services, assisted reproductive technology services, fertility preservation services, and fertility-restoring surgical services.

Assisted reproductive technology services segment held dominating market share in 2025. The segment growth is attributed to ART, which includes IVF, ICSI, and frozen embryo transfer, serving as the definitive treatment pathway for a broad range of infertility causes, spanning both male- and female-factor diagnoses. Moreover, continued laboratory investment and digitization of specimen handling are further reinforcing the segment's central role in fertility service delivery.

• For instance, in April 2025, IVI RMA North America partnered with TMRW Life Sciences to digitize the management and storage of frozen eggs and embryos across its IVF laboratories.

The fertility preservation services segment is anticipated to rise with a CAGR of 10.2% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Infertility Cause

Broader Diagnostic Focus and Age-Related Decline Propelled Female-Factor Infertility Segment Growth

Based on infertility cause, the market is segmented into female-factor infertility, male-factor infertility, and others.

In 2025, the female-factor infertility segment dominated the global market. Female reproductive health has historically been the primary diagnostic focus in fertility workups, encompassing ovulatory disorders, tubal factors, endometriosis, and diminished ovarian reserve. Rising average maternal age is compounding this trend, as egg quantity and quality decline with age, making age-related female-factor infertility an increasingly common diagnosis. Continued research into therapies that address egg quality is expected to sustain clinical and commercial focus on this segment.

The male-factor infertility segment is anticipated to rise with a CAGR of 10.1% over the forecast period.  

By Service Provider

Specialized Infrastructure and Network Expansion Led to Fertility Clinics Segment Growth

Based on service provider, the market is segmented into fertility clinics, hospital-based fertility centers, and others.

In 2025, the fertility clinics segment dominated the global fertility services market share. Dedicated fertility clinics offer specialized infrastructure, concentrated clinical expertise, and streamlined patient journeys purpose-built around reproductive care, distinguishing them from general hospital settings where fertility services are one of many offerings. Ongoing expansion of clinic networks, including the opening of new locations and the addition of specialist physicians, is reinforcing this concentrated, clinic-centered model of care delivery. Furthermore, the segment is set to hold 62.3% share in 2026.

The hospital-based fertility centers segment is anticipated to rise with a CAGR of 8.6% over the forecast period.

Fertility Services Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

Asia Pacific

To get more information on the regional analysis of this market, Download Free sample

Asia Pacific is estimated to reach USD 13.80 billion in 2026 and secure the dominant position in the market. Increasing prevalence of delayed pregnancies, and growing infertility rates due to modern lifestyles is driving the regional market growth.

Japan Fertility Services Market

The Japanese market is estimated at around USD 2.49 billion in 2026, accounting for roughly 7.1% of global revenues.

China Fertility Services Market

China’s market is projected to be one of the largest globally, with 2026 revenues estimated at around USD 5.95 billion, representing roughly 16.9% of global sales.

India Fertility Services Market

The Indian market is estimated at around USD 0.88 billion in 2026, accounting for roughly 2.5% of global revenues.

North America

North America accounted for a substantial share of the market in 2024, valued at USD 9.43 billion, which increased to USD 10.18 billion in 2025, reflecting continued regional market expansion. The market in North America is expected to increase due to expanding employer sponsored fertility benefits and favorable reimbursement policies.

U.S. Fertility Services Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 10.33 billion in 2026, accounting for roughly 29.4% of global sales.

Europe

Europe is projected to record a growth rate of 7.9% in the coming years, and reach a valuation of USD 8.65 billion by 2026. The region is estimated to witness considerable market growth due to structured government backing, and public and insurance-funded access.

U.K. Fertility Services Market

The U.K. market is estimated at around USD 0.92 billion in 2026, representing roughly 2.6% of global revenues.

Germany Fertility Services Market

Germany’s market is projected to reach approximately USD 1.27 billion in 2026, equivalent to around 3.6% of global sales.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin America market growth is attributed to delayed parenthood, declining fertility rates, and increasing participation of women in the workforce. The Latin America market is set to reach a valuation of USD 0.72 billion in 2026. The market in Middle East & Africa is expected to grow due high unmet infertility treatment needs, historically low ART penetration, and increasing healthcare investment in GCC countries.

GCC Fertility Services Market

The GCC market is set to reach a value of USD 0.57 billion in 2026.

South Africa Fertility Services Market

The South African market is projected to reach around USD 0.12 billion in 2026, representing roughly 0.34% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Service Expansion and Strategic Partnerships by Key Players to Strengthen Market Growth

The global fertility services market has a semi-consolidated competitive structure, comprising prominent players such as IVI RMA Global, Jinxin Fertility Group Limited, Virtus Health, Monash IVF Group Limited, and Inception Fertility, LLC. These companies hold significant market positions due to their diversified IVF lab equipment and consumables portfolios, established global distribution and clinic-partner networks, structured employer and payer relationships, and continued investment in digital and AI-enabled embryology and clinic-management platforms.

• For instance, in July 2026, Sapyen partnered with IVF London to expand access to home-based male fertility diagnostics across the U.K.

Other notable players in the global market include Learning Indira IVF Hospital Limited, Kindbody Fertility, Inc., Care Fertility Group Limited, and TFP Fertility Group Ltd. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.

LIST OF KEY FERTILITY SERVICES COMPANIES PROFILED IN REPORT

• IVI RMA Global (Spain)
• Jinxin Fertility Group Limited (China)
• Virtus Health (Australia)
• Monash IVF Group Limited (Australia)
• Inception Fertility, LLC (U.S.)
• Indira IVF Hospital Limited (India)
• Kindbody Fertility, Inc. (U.S.)
• Care Fertility Group Limited (U.K.)
• TFP Fertility Group Ltd (U.K.)
• Nova IVF Fertility (India)  

KEY INDUSTRY DEVELOPMENTS

• July 2026: PS Fertility launched PS Detect, an at-home male fertility test measuring sperm's ability to fertilize an egg, backed by USD 3.5 million in Series A funding.
• April 2026: Legacy relaunched its clinical semen analysis offering at USD 145, expanding access to sperm testing for patients and providers.
• March 2026: Costco partnered with IVI RMA North America and Sesame to launch a fertility care program offering IVF coordination and medication discounts for members.
• January 2026: Progyny launched pregnancy, postpartum, and menopause programs for global employers, extending its existing fertility and family-building offering.
• June 2025: TMRW Life Sciences acquired Cryogatt Systems' patent portfolio, including RFID methodologies for cryogenic specimen tracking.

REPORT COVERAGE

The global fertility services market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a depth competitive landscape with information on the market share and profiles of key operating players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation